Peginterferon alfa-2a (Dong-A)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePeginterferon alfa-2a (Dong-A)

Drug Alias NamePegylated interferon alfa (Dong-A)Pegylated interferon alpha (Dong-A)PEG IFN alpha (Dong-A)Peginterferon α-2a (Dong-A)PEG interferon alpha (Dong-A) +[8]

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionImmunomodulatorsInterferon alpha/beta receptor agonists

TargetsInterferon alpha/beta receptor

Therapy Area/IndicationsHepatitis CHepatitis B

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesDong-A Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesDong-A Pharmaceutical Co Ltd

Active IndicationsN/A

Inactive IndicationsHepatitis CHepatitis B

Other Information

ATC CodeL03AB11